Agenus to unveil bot/bal strategic advancements, key milestones, and future outlook in virtual stakeholder briefing on august 27, 2025

Lexington, mass.--(business wire)---- $agen #colorectalcancer--agenus inc. (“agenus”) (nasdaq: agen), a leader in immuno-oncology, today announced that the company will host a virtual stakeholder briefing on august 27, 2025 at 4:00 p.m. et. the event will feature presentations from senior management and industry thought leaders, offering insights into transformative developments that could shape the future of cancer treatment. the agenda includes a strategic and financial overview, achievements tied to the zydus partnersh.
AGEN Ratings Summary
AGEN Quant Ranking